Skip to main content
. Author manuscript; available in PMC: 2013 Mar 19.
Published in final edited form as: ACS Med Chem Lett. 2012 Dec 26;4(2):175–179. doi: 10.1021/ml300298v

Figure 3.

Figure 3

Efficacy of SL0101 (1) and 7 in MCF-7 cells. Various concentrations of inhibitors were added at time 0 and ATP content was measured after 48 h of treatment. Values are the fold proliferation as a percentage of that obtained with vehicle-treated cells. (n=3 in quadruplicate; bars =SD; * p<0.05 in a student’s t-test compared to the vehicle. ^ p<0.05 in a student’s t-test compared to SL0101 (1)).